INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE, ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) FILES APPLICATION FOR "INHIBITOR OF THE TRANSCRIPTION FACTOR AP-1 FOR USE IN THE TREATMENT OF AGE-RELATED DISEASES"

GENEVA, April 6 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3, Rue Michel Ange75016 Paris), UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE (61 Avenue du General de Gaulle94000 Creteil), ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) (55 boulevard Diderot,75012 Paris) filed a patent application (PCT/EP2024/077143) for "INHIBITOR OF THE TRANSCRIPTION FACTOR AP-1 FOR USE IN THE TREATMENT OF AGE-RELATED DISEASES" on Sep 26, 2024. With publication no. WO/2025/068418, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, whic...